The results indicated that ISL treatment dose‐dependently increases the protein expression level of TRPV1 in HCT116 (Figure 3A,B) and HT29 cells (Figure 3C,D), which showed a similar trend as calcium imaging results in the two CRC cell lines. The gene discussed is TRPV1; the disease is colorectal carcinoma.